| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 80 |
| 1 | NILOTINIB | 77 |
| 2 | ASPIRIN | 63 |
| 3 | ASPIRIN 325 MG | 62 |
| 4 | ASPIRIN 81 MG | 62 |
| 5 | CLOPIDOGREL BISULFATE | 54 |
| 6 | AMLODIPINE | 42 |
| 7 | BISOPROLOL FUMARATE | 38 |
| 8 | PREDNISONE | 36 |
| 9 | APIXABAN | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 1 | DEMECLOCYCLINE | 1 | 0.0044 |
| 2 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 3 | METHAZOLAMIDE | 1 | 0.0029 |
| 4 | QUIZARTINIB | 2 | 0.0028 |
| 5 | PAMABROM | 1 | 0.0027 |
| 6 | NILOTINIB | 77 | 0.0026 |
| 7 | DASATINIB | 22 | 0.0024 |
| 8 | ASCIMINIB | 7 | 0.0020 |
| 9 | PONATINIB HYDROCHLORIDE | 10 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 78 |
| 1 | Corticosteroid [EPC] | 63 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 63 |
| 3 | Factor Xa Inhibitor [EPC] | 62 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 54 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 46 |
| 6 | Kinase Inhibitor [EPC] | 44 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 43 |
| 8 | Calcium Channel Blocker [EPC] | 42 |
| 9 | beta-Adrenergic Blocker [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 6 | 0.0010 |
| 2 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 54 | 0.0005 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Cannabinoid [EPC] | 2 | 0.0002 |
| 9 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |